EMA Authorised: Actraphane (Insulin human) — Novo Nordisk A/S

View source ↗

Summary

Actraphane (insulin human) has been authorised in the EU for the treatment of diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Actraphane (insulin human)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Novo Nordisk A/S. Decision date: 02/02/2024